Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Büscheck

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial CellsMaximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO studyYves-Laurent Bayard, Heyder Omran, Petr Neuzil, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.
Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial CellsMaximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO studyYves-Laurent Bayard, Heyder Omran, Petr Neuzil, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.
Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.
Pageof 12